Pre-Hospital Reduced-Dose Fibrinolysis Coupled With Urgent Percutaneous Coronary Intervention Reduces Time to Reperfusion and Improves Angiographic Perfusion Score Compared With Prehospital Fibrinolysis Alone or Primary Percutaneous Coronary Intervention. Results of the PATCAR Pilot Trial

Journal of the American College of Cardiology

Volumn 50, Issue 16, 2007, Pages 1612-1614

  Smalling, Richard W ^a   Giesler, Gregory M ^a   Julapalli, Vinay R ^a   Denktas, Ali E ^a   Sdringola, Stefano M ^a   Vooletich, Mary T ^a   McCarthy, James J ^a   Bradley, Richard N ^a   Persse, David E ^a   Richter, Bonnie K ^a   Yagi, Masahiro ^a   Fujise, Kenichi ^a   Anderson, H Vernon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOLYTIC AGENT; HEPARIN; RETEPLASE; TENECTEPLASE;

ANALYSIS OF VARIANCE; ANGIOCARDIOGRAPHY; BLEEDING; CORONARY CARE UNIT; DRUG DOSE REDUCTION; ELECTROCARDIOGRAM; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; FISHER EXACT TEST; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFUSION; HUMAN; LETTER; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SCORING SYSTEM; ST SEGMENT ELEVATION; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; FEASIBILITY STUDIES; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PILOT PROJECTS; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 34948904343     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.07.020     Document Type: Letter

References (9)

1. Cannon C.P., Gibson C.M., Lambrew C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000) 2941-2947
2. Boersma E., Maas A.C., Deckers J.W., and Simoons M.L. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 348 (1996) 771-775
3. Brodie B.R., Stuckey T.D., Wall T.C., et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 32 (1998) 1312-1319
4. Gibson C.M., Murphy S.A., Morrow D.A., et al. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. Am Heart J 148 (2004) 336-340
5. Stone G.W., Cox D., Garcia E., et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 104 (2001) 636-641
6. Le May M.R., Wells G.A., Labinaz M., et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). J Am Coll Cardiol 46 (2005) 417-424
7. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 367 (2006) 569-578
8. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 358 (2001) 605-613
9. Thiele H., Scholz M., Engelmann L., et al. ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention. Am J Cardiol 98 (2006) 1132-1139